Cite
HARVARD Citation
Turner, P. et al. (2018). First Results from the ADRRAD Trial – Combination Androgen Deprivation Therapy (ADT), Whole Pelvis Radiotherapy (WPRT) and Radium 223 in Recently Diagnosed Metastatic Hormone Sensitive Prostate Cancer (MHSPCa). Clinical oncology. 30 (3), pp. 196-. [Online].